Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units.
Tissue engineering strategies are gathering clinical momentum in regenerative medicine and are expected to provide excellent opportunities for therapy for difficult-to-treat human pathologies. Being aware of the requirement to produce larger artificial tissue implants for clinical applications, we used microtissues, produced using gravity-enforced self-assembly of monodispersed primary cells, as minimal tissue units to generate scaffold-free vascularized artificial macrotissues in custom-shaped agarose molds. Mouse myoblast, pig and human articular-derived chondrocytes, and human myofibroblast (HMF)-composed microtissues (microm3 scale) were amalgamated to form coherent macrotissue patches (mm3 scale) of a desired shape. Macrotissues, assembled from the human umbilical vein endothelial cell (HUVEC)-coated HMF microtissues, developed a vascular system, which functionally connected to the chicken embryo's vasculature after implantation. The design of scaffold-free vascularized macrotissues is a first step toward the scale-up and production of artificial tissue implants for future tissue engineering initiatives.
Kelm
Jens M
JM
Institute for Chemical and Bio-Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland.
Djonov
Valentin
V
Ittner
Lars M
LM
Fluri
David
D
Born
Walter
W
Hoerstrup
Simon P
SP
Fussenegger
Martin
M
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D019902:Chondrocytes; D005347:Fibroblasts; D006801:Humans; D018919:Neovascularization, Physiologic; D018874:Spheroids, Cellular; D013552:Swine; D023822:Tissue Engineering